Head-to-head · Value Score
Embody vs NewSelf
Two GLP-1 deals, scored on the same six factors. Embody lands a Value Score of 85, NewSelf a 87. Compare their advertised prices, billing terms, and what to check before paying.
Embody
Grade A- · Great Deal
Advertised price
$79/mo month-to-month
$79/mo month-to-month ($49/mo on the 12-month bundle, all doses, compounded)
NewSelf
Grade A- · Great Deal
Advertised price
$134.99/mo at every dose
$134.99/mo at every dose (as low as $99.97 on a longer plan)
Save ~61% vs brand self-payThe verdict
NewSelf takes it on Value Score, 87 to 85 — at an advertised price of $134.99/mo at every dose (as low as $99.97 on a longer plan). We found no advertised teaser step-up. Embody isn't out of it: Shoppers who want one compounded price at every dose, published as a full ladder from month-to-month to a 12-month bundle.
If neither program settles it, the Collective review and the WellMedr review cover two other programs we partner with, and each sets out its price and billing terms so you can run the same comparison.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Embody | NewSelf |
|---|---|---|
| Value Score | 85 (A-) | 87 (A-) |
| Advertised price | $79/mo month-to-month ($49/mo on the 12-month bundle, all doses, compounded) | $134.99/mo at every dose (as low as $99.97 on a longer plan) |
| Save vs brand self-pay | — | ~61% |
| Semaglutide | $79/mo month-to-month ($49/mo on the 12-month bundle, all doses, compounded) | $134.99/mo at every dose (as low as $99.97 on a longer plan) |
| Tirzepatide | $129/mo month-to-month ($99/mo on the 12-month bundle, all doses, compounded) | $224.99/mo at every dose (as low as $144.49 on a longer plan) |
| Both molecules | Yes | Yes |
| Pricing | Watch | Flat — no step-up |
| Coverage | All 50 states | 49 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Embody
Embody offers compounded semaglutide and tirzepatide via injection plus a unique compounded oral tirzepatide gum formulation.
What's good
- Among the lowest compounded prices tracked here, and the same at every dose: $79 a month for semaglutide and $129 for tirzepatide billed monthly, per Embody's own terms
- Unique compounded oral tirzepatide gum formulation — alternative for patients who prefer not to inject
- Available in all 50 states with no insurance friction
- 24/7 unlimited clinician messaging and dose-adjustment support included
- Medical leadership by Dr. Alan Viglione, board-certified in Internal Medicine
The fine print
- The $49 and $99 homepage headlines are 12-month bundle rates; billed monthly the same products are $79 and $129, and a 'save $200' sale banner sits beside them
- Compounded only — no FDA-approved brand-name Ozempic, Wegovy, Zepbound, or Mounjaro option
- Pharmacy partners not publicly named — compounding source transparency is limited
- Compounded oral tirzepatide does not have an FDA-approved counterpart, and oral GLP-1 bioavailability remains an active area of clinical debate
NewSelf
NewSelf sells compounded semaglutide with B12 or glycine at $134.99 a month and compounded tirzepatide with B6 and glycine at $224.99, both held flat across every dose, in 49 states.
Why it's a deal
- The rate holds at every dose on both molecules — semaglutide across 0.25 mg to 2.5 mg, tirzepatide across 2.5 mg to 15 mg — so titrating up costs nothing extra
- Both products are compounded with B12, B6 or glycine rather than sold as bare molecules, and the formulation is stated on the product card
- HSA and FSA eligible, with the health screening, shipping and ongoing support inside the price
- Names the 49 states it covers rather than implying nationwide reach
The fine print
- The prominent $99.97 and $144.49 figures are plan floors, not the standing rates — those are $134.99 and $224.99
- Not available in Mississippi or Louisiana
- A "Tirzepatide Plus" tier at $399 a month sits above the standard product, so the flat-rate promise applies within a tier rather than across the range
- Compounded only — no FDA-approved brand-name route
We earn a commission when you start treatment through some links on this site, at no extra cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Embody is ranked on the Embody alternatives ranking, and the same list for the other side is on alternatives to NewSelf.
More head-to-heads
The programs scoring closest to this pair, side by side.
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. "% vs brand-name self-pay" compares a program's lowest disclosed monthly price against $349/mo, Wegovy's self-pay price at NovoCare Pharmacy, every standard dose after the two-month intro offer (checked October 2026). Prices change — confirm on each provider's site. Not medical advice; see our disclosure.